achievingadvancesagentsamyloidosisantiantibodiesapproachesasctashassociatedbasedbcmabelantamabbispecificcartitudecelcellcelmodsciltaclinicalcombinationcombinationsconsolidationcurecurrentdatadirecteddiscussiondiseaseearlyelderlyeligibleevaluatedexperiencefuturehighimmuneimmunotherapiesimpactincludinginductioninfectionsintegratingisatuximabkrdlatestlenlenalidomidemafodotinmaintenancemelphalanmicrobiomemightmmmrdndmmneedneedsnovelovercomeparadigmpatientspfspracticeprognosisqolrationalerealrefractoryregimensrelapserelapsedresponseriskrolerrmmsmolderingstandardstillsymposiumtherapiestherapytransplanttransplantationtreattreatingtreatmenttrialunderstandingunmetupdatesuseversusworld